Cytology in Barrett's esophagus

Gastrointestinal Endoscopy Clinics of North America

Volumn 13, Issue 2, 2003, Pages 335-348

  Falk, Gary W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BARRETT ESOPHAGUS; BRUSH BORDER; CANCER DIAGNOSIS; CANCER RISK; CELL ADHESION; COST EFFECTIVENESS ANALYSIS; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DYSPLASIA; EPITHELIUM CELL; ESOPHAGUS BIOPSY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MEDICAL PRACTICE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; REVIEW; RISK ASSESSMENT;

EID: 0037841863     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-5157(03)00016-3     Document Type: Review

References (49)

1. Streitz JM, Andrews CW, Ellis FH. Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg 1993;105:383-8.
2. Van Sandick JW, Lanschot JJ, Kuiken BW, et al. Impact of endoscopic biopsy surveillance of Barrett's esophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998;43:216-22.
3. Peters JH, Clark GW, Ireland AP, et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. Thorac Cardiovasc Surg 1994;108:813-22.
4. Corley DA, Levin TR, Habel LA, et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 2002;122:633-40.
5. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002;97:1887-95.
6. Falk GW. Barrett's esophagus. Gastroenterology 2002;122:1569-91.
7. Alikhan M, Rex D, Khan A, et al. Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. Gastrointest Endosc 1999;50:23-6.
8. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett's esophagus: a reaffirmation. Hum Pathol 2001;32:368-78.
9. Reid BJ, Haggitt RC, Rubin CE. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19:166-78.
10. Falk GW, Ours TM, Richter JE. Practice patterns for surveillance of Barrett's esophagus in the United States. Gastrointest Endosc 2000;52:197-203.
11. Gross CP, Canto MI, Hixson J, Powe NR. Management of Barrett's esophagus: a national study of practice patterns and their cost implications. Am J Gastroenterol 1999;94:3440-7.
12. Ackroyd R, Wakefield SE, Williams JL, et al. Surveillance of Barrett's esophagus: a need for guidelines. Dis Esophagus 1997;10:185-9.
13. Chambers LA, Clark WE. The endoscopic diagnosis of gastroesophageal malignancy. A cytologic review. Acta Cytol 1986;30:110-4.
14. Cusso X, Mones-Xiol J, Vilardell F. Endoscopic cytology of cancer of the esophagus and cardia: a long-term evaluation. Gastrointest Endosc 1989;35:321-3.
15. Geisinger KR. Endoscopic biopsies and cytologic brushings of the esophagus are diagnostically complementary. Am J Clin Pathol 1995;103:295-9.
16. Alexander JA, Jones SM, Smith CJ, et al. Usefulness of cytopathology and histology in the evaluation of Barrett's esophagus in a community hospital. Gastrointest Endosc 1997;46:318-20.
17. Geisinger KR, Teot LA. Role of histology and cytology in esophageal disease. In: Castell DO, Richter JE, editors. The esophagus. 3rd edition. Philadelphia: Lippincott, Williams, and Wilkins; 1999. p. 145-64.
18. Wang HH, Sovie S, Trawinski G, et al. ThinPrep processing of endoscopic brushing specimens. Am J Clin Pathol 1996;105:163-7.
19. Biscotti CV, Hollow JA, Toddy SM, Easley KA. ThinPrep versus conventional smear cytologic preparations in the analysis of thyroid fine needle aspiration specimens. Am J Clin Pathol 1995;104:150-3.
20. Falk GW, Chittajallu R, Goldblum JR, et al. Surveillance of Barrett's esophagus for dysplasia and cancer with balloon cytology. Gastroenterology 1997;112:1787-97.
21. Geisinger KR, Teot LA, Richter JE. A comparative cytopathologic, histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus. Cancer 1992;69:8-16.
22. Wang HH, Doria MI, Purohit-Buch S, et al. Barrett's esophagus: the cytology of dysplasia in comparison to benign and malignant lesions. Acta Cytol 1992;36:60-4.
23. Wang HH, Ducatman BS, Thibault S. Cytologic features of premalignant glandular lesions in the upper gastrointestinal tract. Acta Cytol 1991;35:199-203.
24. Belladonna JA, Hadju SI, Bains MS, Winawer SJ. Adenocarcinoma in situ of Barrett's esophagus diagnosed by endoscopic cytology. N Engl J Med 1974;291:895-6.
25. Robey SS, Hamilton SR, Gupta PK, Erozan YS. Diagnostic value of cytopathology in Barrett esophagus and associated carcinoma. Am J Clin Pathol 1988;89:493-8.
26. Geisinger KR, Teot LA, Richter JE. A comparative cytopathologic, histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus. Cancer 1992;69:8-16.
27. Hardwick RH, Morgan RJ, Warren BF, et al. Brush cytology in the diagnosis of neoplasia in Barrett's esophagus. Dis Esophagus 1997;10:233-7.
28. Dar M, Gramlich T, Falk G. Endoscopic brush cytology in Barrett's esophagus: highly specific but less sensitive than previously reported [abstract]. Gastrointest Endosc 2002;55:AB200.
29. Wang HH, Sovie S, Zeroogian JM, et al. Value of cytology in detecting intestinal metaplasia and associated dysplasia at the gastroesophageal junction. Hum Pathol 1997;28:465-71.
30. Tsai TT, Bongiorno PF, Orringer MB, Beer DG. Detection of p53 nuclear protein accumulation in brushings and biopsies of Barrett's esophagus. Cancer Detect Prev 1997;21:326-31.
31. Van Laetham JL, Bourgeois V, Parma J, et al. Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases. Gastrointest Endosc 1998;47:479-85.
32. Morales CP, Burdick JS, Saboorian MH, et al. In situ hybridization for telomerase RNA in routine cytologic brushings for the diagnosis of pancreaticobiliary malignancies. Gastrointest Endosc 1998;48:402-5.
33. Lutzke L, Pacifico R, Wanf K, et al. Digital image analysis and brush cytology is better than cytology alone for detection of Barrett's esophagus with high-grade dysplasia [abstract]. Gastroenterology 2002;122:A289.
34. Rumalla A, Baron TH, Leontovich O, et al. Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis. Mayo Clin Proc 2001;76:29-33.
35. Hu N, Taylor PR, Rao JY, et al. Quantitative fluorescence image analysis of DNA content and nuclear morphology on esophageal balloon cytology smears and subsequent development of esophageal and gastric cardia cancer in Linxian, China. Cancer Epidemiol Biomarkers Prev 1998;7:59-64.
36. Halling KC, King W, Sokolova IA, et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 2000;164:1768-75.
37. Jiang F, Katz RL. Use of interphase fluorescence in situ hybridization as a powerful diagnostic tool in cytology. Diagn Mol Pathol 2002;11:47-57.
38. Skacel M, Gramlich TL, Fahmy MM, et al. Fluorescence in situ hybridization of cytologic specimens from Barrett's esophagus and adenocarcinoma. Gastrointest Endosc 2002;55:AB199.
39. Krishnadath S, Wang K, Halling K, et al. Detection of cytogenetic abnormalities by multi-color FISH in brush cytology [abstract]. Gastroenterology 2002;122:A289.
40. Richter JE. Endoscopic surveillance of Barrett's esophagus: another viewpoint. Am J Gastroenterol 1993;88:630-2.
41. Shu YJ. Cytopathology of the esophagus. Acta Cytol 1983;27:7-16.
42. Shen Q, Liu SF, Dawsey SM, et al. Cytologic screening for esophageal cancer: results from 12877 subjects from a high-risk population in China. Int J Cancer 1993;54:185-8.
43. Dawsey SM, Yu Y, Taylor PR, et al. Esophageal cytology and subsequent risk of esophageal cancer. A prospective follow-up study from Linxian, China. Acta Cytol 1994;38:183-92.
44. Liu SF, Shen Q, Dawsey SM, et al. Esophageal balloon cytology and subsequent risk of esophageal and gastric-cardia cancer in a high risk Chinese population. Int J Cancer 1994;57:775-80.
45. Fennerty MB, DiTomasso J, Morales TG, et al. Screening for Barrett's esophagus by balloon cytology. Am J Gastroenterol 1995;90:1230-2.
46. Brandt LJ, Coman E, Schwartz E, et al. Use of a new cytology balloon for diagnosis of symptomatic esophageal disease and acquired immunodeficiency syndrome. Gastrointest Endosc 1993;39:559-61.
47. Rader AE, Faigel DO, Ditomasso J, et al. Cytologic screening for Barrett's esophagus using a prototype flexible mesh catheter. Dig Dis Sci 2001;46:2681-6.
48. Falk GW, Provencher KA, Gramlich TG, Richter JE. Surveillance of Barrett's esophagus with a modified nonendoscopic cytology device: a pilot study [abstract]. Gastrointest Endosc 2001; 53:AB157.
49. Qureshi WA, El-Zimaity H, Green LK, Graham DY. Screening for Barrett's esophagus: searching for a new technique. Am J Gastroenterol 2002;97:1565-6.